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REPLY TO RUAN ET AL. (2017): NON-MEDICAL
USE OF PRESCRIPTION OPIOIDS IS
ASSOCIATEDWITH HEROIN INITIATION
AMONG US VETERANS
We thank Ruan and colleagues for their letter and
appreciate their comments regarding our recent
study [1], which demonstrated an independent associa-
tion between non-medical use of prescription opioids
(NMUPO) and heroin initiation among US veterans [2].
Our results indicate that participants who reported prior
or concurrent NMUPO had 5.43 times the adjusted haz-
ard of heroin initiation, compared to participants who
reported no NMUPO [95% confidence interval
(CI) = 4.01–7.35]. While we acknowledge in our paper
that these results are not necessarily generalizable to all
US veterans, given the inclusion of participants who are
HIV-infected and/or hepatitis C virus (HCV)-infected, the
observed effect of NMUPO on risk for heroin initiation
was robust to sensitivity analyses. For example, as de-
scribed in our published study, excluding the 701 HCV-
positive participants did not affect the result [adjusted
hazard ratio (AHR) = 6.21, 95% confidence interval
(CI) = 4.54–8.51)] meaningfully. In light of the concerns
raised by Ruan and colleagues, we repeated the analysis
excluding HIV-infected individuals, and in fact found
that the relationship between NMUPO and heroin initia-
tion was stronger (AHR = 7.01, 95% CI = 5.40–9.09).
Thus, although the observed absolute rate of heroin
initiation may be greater than in the general US veteran
population due to the specific inclusion of higher-risk pa-
tients, it does not appear that the relationship between
NMUPO and heroin initiation is affected by HCV or
HIV prevalence.
Ruan and colleagues also highlighted the increase in
heroin-related deaths from 2013 to 2014, with the con-
current decrease in people reporting non-medical use of
prescription opioids. This inverse relationship may, in
fact, be attributable to the fact that large numbers of
people who developed opioid use disorder (as a result of
non-medical use of prescription opioids) have transitioned
subsequently to heroin use [3,4]. The trend between
increased rates of death associated with heroin use and
decreased rates of death associated with use of pres-
cription opioids thus speaks to the potential role of
transitioning from the misuse of prescription opioids to
the use of heroin in many parts of the country [5,6].
This phenomenon is consistent with the findings of our
paper, given that NMUPO may be one step in a complex,
multi-step cascade that increases risk of transition to
heroin use in the population [7,8].
Additionally, while Compton and colleagues noted
that: ‘only a small percentage of non-medical users of
prescription opioids initiate heroin use’, they also go on
to say that: ‘given the large number of nonmedical
users, even a small percentage who initiate heroin use
translates into several hundred thousand new heroin
users’ [9]. Ruan et al. cite a statistic that 3.6% of the
people reporting NMUPO initiated heroin use within
5 years of beginning NMUPO. Indeed, even this small
percentage, if correct, would result in approximately
370800 individuals initiating heroin use by 2019. Prior
and subsequent years would contribute similar
proportions of individuals initiating heroin due to
NMUPO [10].
In conclusion, we appreciate that the rates of heroin
initiation in our study are potentially higher compared to
rates of heroin initiation among studies that do not include
HIV- and HCV-infected veterans. However, this limitation
does not obscure the primary findings of our study, which
speaks to the observed increased relative risk of heroin
initiation among participants who report prior/concurrent
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DRUG TESTING IN FORENSIC MENTAL
HEALTH SETTINGS
The use of illicit substances is extremely common among
forensic psychiatry populations and is recognized widely
as one of the most potent risk factors for interpersonal
violence. Detection and management of substance misuse
in patients prone to behave violently is critical for
maintaining the safety of patients, staff members and the
public at large. The most commonly used specimen type
in UK mental health settings is urine [1]. This was, until
recently, the case at the State Hospital, the high-security
psychiatric hospital for Scotland and Northern Ireland.
In 2013 we reported on the results of a pilot study in
which patients in high security were offered the choice of
either urine or oral fluid testing (OFT) [2]. The pilot was
successful, with oral fluid testing being generally preferred
by both patients and staff members. The additional
financial cost at that time was considered to be outweighed
by the significant benefits arising from offering patients
choice, preservation of patient dignity and staff time
savings. As a result of the successful pilot, since 2010 all
patients at the State Hospital have been offered the choice
of either urine or OFT for routine testing for illicit
substances, a move which was viewed positively by the
Mental Welfare Commission.
We provide an update on our experience since 2010 as,
to our knowledge, we are the only secure psychiatric
setting which routinely offers patients the choice of
drug-testing method. Prior to the pilot study, urine testing
represented more than 99% of testing. In 2010 testing by
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